C08B - Polysaccharides; Derivatives thereof

More topics under "C08B - Polysaccharides; Derivatives thereof" (46,014)
C08B 1 - Preparatory treatment of cellulose for making derivatives thereof (2,184)
C08B 11 - Preparation of cellulose ethers (2,701)
C08B 13 - Preparation of cellulose ether-esters (380)
C08B 15 - Preparation of other cellulose derivatives or modified cellulose (3,279)
C08B 16 - Regeneration of cellulose (397)
C08B 17 - Apparatus for esterification or etherification of cellulose (126)
C08B 3 - Preparation of cellulose esters of organic acids (1,677)
C08B 30 - Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin (4,390)
C08B 31 - Preparation of chemical derivatives of starch (4,906)
C08B 33 - Preparation of chemical derivatives of amylose (486)
C08B 35 - Preparation of chemical derivatives of amylopectin (363)
C08B 37 - Preparation of polysaccharides not provided for in groups; Derivatives thereof (24,467)
C08B 5 - Preparation of cellulose esters of inorganic acids (387)
C08B 7 - Preparation of cellulose esters of both organic and inorganic acids (67)
C08B 9 - Preparation of cellulose xanthate or viscose (204)

Patents for C08B - Polysaccharides; Derivatives thereof (243)
04/2003
04/16/2003	EP0806942B1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
04/09/2003	EP0986580B1 Oligosaccharide mixtures having antithrombotic activity
02/2003
02/27/2003	US20030040487 Polymer complexes of glucuronoglucanes
02/13/2003	WO2003011912A1 Chitosan preparation
02/13/2003	CA2455777A1 Chitosan preparation
01/2003
01/08/2003	EP0980391B1 Procedure for producing uronic acid blocks from alginate
11/2002
11/26/2002	US6486137 Oligosaccharide mixtures having antithrombotic activity
09/2002
09/04/2002	CN1090193C Procedure for producing uronic acid blocks from alginate
09/04/2002	CN1090192C Volatile linear siloxanes mixture
06/2002
06/12/2002	CN1086189C Ultra-fine microcrystalline cellulose compositions and process for their manufacture
05/2002
05/30/2002	US20020065411 Starch
04/2002
04/18/2002	US20020045745 Washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins; molecular weight reduction by shearing
03/2002
03/28/2002	WO2002024754A1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
02/2002
02/26/2002	US6350440 Mixtures of volatile linear siloxanes
01/2002
01/02/2002	EP1165619A1 Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique
01/02/2002	EP0958307B1 O-sulfated bacterial polysaccharides
12/2001
12/12/2001	EP1162009A2 Die-holder/tray assembly with anti-rotation means for die-forming machines
09/2001
09/11/2001	US6288044 O-sulfated bacterial polysaccharides
08/2001
08/22/2001	CN1309666A Polymer composition of glucuronic acid glucosan
08/09/2001	US20010012837 Anti-ulcer composition
07/2001
07/31/2001	CA1341276C Hyaluronic acid esters and salts
07/18/2001	EP1115747A1 Polymer complexes of glucuronoglucanes
07/05/2001	US20010006957 Microdispersed or microfibrillar polyanhydroglucuronic acids and salts, complex salts or intermolecular polymer complexes suitable for fixing drug dosages with significantly protracted effect and reduced toxicity
06/2001
06/14/2001	US20010003742 Antilipemic formulation
05/2001
05/16/2001	EP1098663A1 Slow release formulations comprising anionic polysaccharide
05/16/2001	EP1098654A1 Antilipemic composition comprising a polysaccharide containing glucuronic acid
05/16/2001	EP1098640A1 Anti-ulcer composition comprising a polysaccharide containing glucuronic acid
04/2001
04/12/2001	WO2000004891A3 Anti-ulcer composition
01/2001
01/03/2001	CN1278830A Ultra-fine microcrystalline cellulose compositions and process for their manufacture
12/2000
12/06/2000	EP0675733B1 Peptide-carbohydrate conjugates generating t-cell immunity
10/2000
10/19/2000	WO2000061640A1 Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique
09/2000
09/19/2000	US6121441 Hydrolyzing an alginate with an acid so as to form an undissolved fraction containing g blocks and m blocks, and a dissolved fraction containing mg blocks, and suspending said undissolved fraction in water and adjusting the ph
08/2000
08/01/2000	CA2026036C Sulphated glycosamino glycuronan with antithrombotic activity
07/2000
07/26/2000	CN1261375A Procedure for producing uronic acid blocks from alginate
07/05/2000	CN1259143A Oligosaccharide mixtures having antithrombotic activity
03/2000
03/22/2000	EP0986580A1 Oligosaccharide mixtures having antithrombotic activity
03/22/2000	CN1247868A Volatile linear siloxanes mixture
03/07/2000	US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby
02/2000
02/23/2000	EP0980885A1 Mixtures of volatile, linear siloxanes
02/23/2000	EP0980391A1 Procedure for producing uronic acid blocks from alginate
02/03/2000	WO2000005269A1 Polymer complexes of glucuronoglucanes
02/03/2000	WO2000004939A1 Dental pin
02/03/2000	WO2000004937A1 Flat flexible materials
02/03/2000	WO2000004925A1 Slow release formulations comprising anionic polysaccharide
02/03/2000	WO2000004907A1 An antilipemic formulation
02/03/2000	WO2000004891A2 Anti-ulcer composition
02/03/2000	WO2000004882A1 Formulations of anionic polysaccharides
02/03/2000	WO2000004877A1 Suppository formulations comprising anionic polysaccharide
01/2000
01/05/2000	DE19837850C1 Organosiloxane mixture useful as volatile carrier in cosmetic formulations
11/1999
11/24/1999	EP0958307A1 O-sulfated bacterial polysaccharides
08/1999
08/11/1999	EP0827514B1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
12/1998
12/10/1998	WO1998055514A1 Oligosaccharide mixtures having antithrombotic activity
12/10/1998	CA2293587A1 Oligosaccharide mixtures having antithrombotic activity
11/1998
11/19/1998	WO1998051710A1 Procedure for producing uronic acid blocks from alginate
10/1998
10/06/1998	US5817780 Process for the alkaline oxidative degradation of reducing sugars
09/1998
09/15/1998	US5807559 Compositions for generating T cell immunity against carbohydrate structures
08/1998
08/13/1998	WO1998034958A1 O-sulfated bacterial polysaccharides
03/1998
03/11/1998	EP0827514A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
11/1997
11/19/1997	EP0807126A1 Process for the alcaline oxidative degradation of reducer sugars and products thus obtained
11/19/1997	EP0806942A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
11/12/1997	EP0600928B1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
10/1997
10/14/1997	CA2057106C Dissolving method
09/1997
09/16/1997	US5667803 Excipient in controlled release formulations, adjusting degree of substitution and compression force to control release properties
07/1997
07/29/1997	CA1339113C Family of xanthan-based polysaccharide polymers including non-acetylatedand/or non-pyruvylated gum and acetylated or non-acetylated polytetramergum
07/01/1997	CA2027133C Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them
06/1997
06/12/1997	WO1997020860A1 Process for the alcaline oxidative degradation of reducer sugars and products thus obtained
04/1997
04/02/1997	EP0765939A2 Family of xanthan-based polysaccharide polymers including non-acetylated and/or non-pyruvylated gum
03/1997
03/19/1997	EP0600934B1 Oligosaccharides of dermatan sulphate, process for their production, and associated pharmaceutical compositions
11/1996
11/14/1996	WO1996035720A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
08/1996
08/20/1996	US5547944 An oligosaccharide sequence with a high degree of sulfation
06/1996
06/05/1996	EP0569383B1 LOW-MOLECULAR SULPHATED POLY-$g(b)-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS
02/1996
02/14/1996	EP0696598A1 Polysaccharide esters and their salts
12/1995
12/14/1995	WO1995033450A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
12/14/1995	CA2190181A1 Starch acetate composition with modifiable properties, method for preparation and usage thereof
10/1995
10/11/1995	EP0675733A1 Peptide-carbohydrate conjugates generating t-cell immunity
08/1995
08/02/1995	CN1106021A Method for the separation of bacterial lipopolysaccharides from protein-containing solutions
02/1995
02/21/1995	CA1334516C Process for preparing high-purity dermatan sulphate, and pharmaceutical compositions which contain it
01/1995
01/27/1995	CA2128547A1 Method for the separation of bacterial lipopolysaccharides from protein-containing solutions
08/1994
08/09/1994	US5336767 Total or partial esters of hyaluronic acid
06/1994
06/15/1994	EP0600928A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
04/1994
04/12/1994	CA1328404C Pharmaceutical combination product and the preparation and use thereof
02/1994
02/22/1994	US5288317 Dissolving method
01/1994
01/18/1994	US5280016 Inhibitor of smooth muscle cell proliferation at low concentration
01/12/1994	EP0577756A1 New non-anticoagulant heparin derivatives
01/12/1994	EP0577716A1 New non-anticoagulant heparin derivatives
01/12/1994	EP0577665A1 Anticoagulants and processes for preparing such
12/1993
12/01/1993	EP0571416A1 (carboxyl)alkyloxyalkyl derivatives of cyclodextrins
11/1993
11/11/1993	WO1993021948A1 Peptide-carbohydrate conjugates generating t-cell immunity
11/11/1993	CA2134097A1 Peptide-carbohydrate conjugates generating t-cell immunity
10/1993
10/05/1993	US5250519 Non-anticoagulant heparin derivatives
08/1993
08/11/1993	EP0323952B1 Family of xanthan-based polysaccharide polymers including non-acetylated and/or non-pyruvylated gum and acetylated or non-acetylated polytetramer gum
05/1993
05/05/1993	EP0288494B1 Modification of alginates or other uronic acid compounds by treatment with co 2
03/1993
03/30/1993	US5198430 Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them
03/18/1993	WO1993005075A1 Oligosaccharides of dermatan sulphate, process for their production, and associated pharmaceutical compositions
03/18/1993	WO1993005074A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
03/18/1993	CA2116437A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutica l forms containing it
11/1992
11/17/1992	US5164377 Sulphated glycosaminoglycuronan with antithrombotic activity
11/04/1992	EP0511690A2 Family of xanthan-based polysaccharide polymers including non-acetylated and/or non-pyruvylated gum
10/1992
10/20/1992	CA1308929C Composition for application to a soil or plant locus
09/1992
09/30/1992	WO1992017188A1 New non-anticoagulant heparin derivatives

1 2 3